Small-molecule modulators of the OX40-OX40 ligand co-stimulatory protein-protein interaction-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Small-molecule modulators of the OX40-OX40 ligand co-stimulatory protein-protein interaction

Published:2014-10-24 Issue:21 Volume:171 Page:4955-4969
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:Br J Pharmacol

Author:

Song Yun¹,Margolles-Clark Emilio²,Bayer Allison³⁴,Buchwald Peter¹³

Affiliation:

1. Department of Molecular and Cellular Pharmacology; University of Miami; Miami FL USA

2. Department of Surgery; Division of Transplants; University of Miami; Miami FL USA

3. Diabetes Research Institute; University of Miami; Miami FL USA

4. Department of Microbiology and Immunology; Miller School of Medicine; University of Miami; Miami FL USA

Funder

National Institutes of Health National Institute of Allergy and Infectious Diseases

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bph.12819/fullpdf

Reference53 articles.

1. The Concise Guide to PHARMACOLOGY 2013/14: Catalytic receptors;Alexander;Br J Pharmacol,2013

2. Small-molecule inhibitors of protein-protein interactions: progressing towards the dream;Arkin;Nat Rev Drug Discov,2004

3. Operational models of pharmacological agonism;Black;Proc R Soc Lond B Biol Sci,1983

4. Retrometabolic Drug Design and Targeting

5. Antigen-specific prevention of type 1 diabetes in NOD mice is ameliorated by OX40 agonist treatment;Bresson;J Autoimmun,2011

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Small Molecule Targeting Immune Cells: A Novel Approach for Cancer Treatment;Biomedicines;2023-09-24

2. Oncolytic Efficacy of a Recombinant Oncolytic Virus Carrying OX40L inHepatocellular Carcinoma;PROG BIOCHEM BIOPHYS;2022

3. Broad-Spectrum Small-Molecule Inhibitors of the SARS-CoV-2 Spike—ACE2 Protein–Protein Interaction from a Chemical Space of Privileged Protein Binders;Pharmaceuticals;2022-08-30

4. Theoretical premises of a “three in one” therapeutic approach to treat immunogenic and nonimmunogenic cancers: a narrative review;Translational Cancer Research;2021-11

5. Combining nanomedicine and immune checkpoint therapy for cancer immunotherapy;WIREs Nanomedicine and Nanobiotechnology;2021-07-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3